Back to Candriam S.C.A. Candriam S.C.A.

ABTABT
Showing 8 of 30 quarters

Position history for Candriam S.C.A.Candriam S.C.A.'s holdings in ABBOTT LABORATORIES

Candriam S.C.A. holds 211,167 shares of ABT (ABBOTT LABORATORIES), worth $19.1M as of 2026-Q2. The position was decreased (-66.2% shares). ABT represents 0.1% of Candriam S.C.A.'s portfolio.

Current Value

$19.1M

Current Shares

211,167

Total Value Change

-$18.3M

Total Shares Change

-116,838

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
211,167
-66.2%
$19.1M0.1%$90.10
0
2026-Q1
Decreased
624,438
-38.7%
$64.1M0.3%$101.31
0
2025-Q4
Decreased
1M
-13.1%
$127.7M0.6%$123.00
0
2025-Q3
Increased
1.2M
+12.0%
$157M0.8%$130.91
48
2025-Q2
Increased
1M
+63.8%
$142.4M0.8%$132.34
62
2025-Q1
Increased
639,070
+7.6%
$84.8M0.5%$128.48
45
2024-Q4
Increased
593,755
+81.0%
$67.2M0.4%$108.98
54
2024-Q3
Decreased
328,005
-8.8%
$37.4M0.2%$109.33
0

Other major holders of ABT: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used